NYSE$GHM
Graham Corp · Q2 2026 earnings
Q2 2026 earnings · · Before market open · Investor relations
Briefing
GHM reported Q2 2026, revenue of $66M, net income of $3.1M.
For Q2 2026, GHM reported revenue of $66M, net income of $3.1M. Management discusses operating trends, liquidity, and strategic priorities as disclosed in the quarterly filing.
- Revenue $66M.
- Net income $3.1M.
- GHM updated clinical, capital, or portfolio priorities in the filing.
Headline financials
Revenue & EPS history
Graham · Revenue · Quarterly
$66M
Forward guidance
Management discusses GHM's outlook, capital deployment, and key risks as disclosed in the earnings materials and periodic report.
Tailwinds
- GHM cited progress on strategic priorities in the quarterly filing.
- Liquidity and balance sheet support continued operations and investment.
Headwinds
- Macro, competitive, and regulatory factors may affect near-term results.
- R&D, credit, or project timing can create quarter-to-quarter volatility.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q2 2026
+0.1%
Avg return
Earnings day
+2.5%
Avg return
5 days after
+2.7%
Avg return
30 days after
54%
35 / 65 earnings
Positive
+22.9%
Q2 2025
Best reaction
-25.5%
Q3 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2026 | -10.3% | -2.7% | — | |
| Q3 2026 | +12.9% | +19.7% | +10.7% | |
| Q2 2026 | +0.5% | -2.0% | -6.8% | |
| Q1 2026 | -18.3% | -15.9% | -14.4% | |
| Q4 2025 | +6.3% | +10.1% | +25.7% | |
| Q3 2025 | -17.4% | -20.4% | -31.9% | |
| Q2 2025 | +22.9% | +24.6% | +29.6% | |
| Q4 2024 | +12.6% | +17.7% | +7.7% | |
| Q3 2024 | +11.7% | +15.9% | +20.8% | |
| Q2 2024 | -4.4% | +1.4% | +6.2% | |
| Q1 2024 | +15.7% | +20.3% | +17.3% | |
| Q1 2025 | +15.7% | +20.3% | +17.3% | |
| Q4 2023 | +11.1% | +11.1% | +11.3% | |
| Q3 2023 | +11.6% | +16.4% | +32.7% | |
| Q2 2023 | +18.1% | +16.6% | +13.5% | |
| Q1 2023 | +12.3% | +17.7% | +44.7% | |
| Q4 2022 | +16.4% | +20.6% | -9.0% | |
| Q3 2022 | -25.5% | -23.0% | -34.1% | |
| Q2 2022 | -3.2% | -1.5% | -1.8% | |
| Q1 2022 | -4.8% | -9.7% | -9.3% | |
| Q4 2021 | +2.3% | -0.1% | -6.7% | |
| Q3 2021 | -5.3% | -2.7% | -1.5% | |
| Q2 2021 | -0.3% | +1.5% | +21.6% | |
| Q1 2021 | +6.1% | +5.8% | +8.6% | |
| Q4 2020 | -10.1% | -10.1% | -13.7% | |
| Q3 2020 | -7.8% | -10.8% | -17.2% | |
| Q2 2020 | +10.4% | -2.0% | -7.0% | |
| Q1 2020 | +1.2% | +1.8% | -11.7% | |
| Q4 2019 | +0.0% | +1.4% | -0.9% | |
| Q3 2019 | -1.5% | -1.1% | -0.8% | |
| Q2 2019 | +1.0% | +1.2% | -10.4% | |
| Q1 2019 | +3.5% | +10.0% | +9.4% | |
| Q4 2018 | +1.2% | -1.3% | -1.5% | |
| Q3 2018 | +5.9% | +0.5% | -6.9% | |
| Q2 2018 | -10.4% | -11.1% | -10.0% | |
| Q1 2018 | -3.1% | -3.0% | -0.9% | |
| Q4 2017 | -0.7% | -3.5% | -6.1% | |
| Q3 2017 | +3.4% | -0.3% | +3.5% | |
| Q2 2017 | -0.1% | -3.6% | +24.4% | |
| Q1 2017 | -4.3% | -4.2% | +3.0% | |
| Q4 2016 | -4.8% | -1.1% | +1.2% | |
| Q3 2016 | +0.2% | — | — | |
| Q2 2016 | -3.4% | — | — | |
| Q1 2016 | +8.8% | — | — | |
| Q4 2015 | -5.9% | — | — | |
| Q3 2015 | -8.9% | — | — | |
| Q2 2015 | +0.1% | — | — | |
| Q1 2015 | -3.4% | — | — | |
| Q4 2014 | +6.5% | — | — | |
| Q3 2014 | -4.6% | — | — | |
| Q2 2014 | -2.8% | — | — | |
| Q1 2014 | +5.2% | — | — | |
| Q4 2013 | +13.6% | — | — | |
| Q3 2013 | +1.8% | — | — | |
| Q2 2013 | +0.9% | — | — | |
| Q1 2013 | +1.2% | — | — | |
| Q4 2010 | -0.6% | — | — | |
| Q4 2012 | -6.5% | — | — | |
| Q3 2011 | +0.5% | — | — | |
| Q3 2012 | +0.5% | — | — | |
| Q2 2012 | +6.3% | — | — | |
| Q4 2011 | -17.6% | — | — | |
| Q2 2011 | -17.6% | — | — | |
| Q1 2011 | -17.6% | — | — | |
| Q1 2012 | -17.6% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro